Dr. Timothy Hanna

Clinician-Scientist I

Working within the Ontario Institute for Cancer Research/Cancer Care Ontario Health Services Research Program, and based in the Queen’s Cancer Research Institute (QCRI) Division of Cancer Care and Epidemiology (CCE), Dr. Timothy Hanna’s research focuses on three translational streams of health services research: quality of care, value of care and access to care.

As a cancer health services researcher, Hanna’s findings help identify ways to improve population health by driving improvements in cancer care delivery. His goal is to translate cutting-edge knowledge from clinical trials into widely adopted, accessible and high-quality interventions available to all Ontarians who need them.

Hanna’s vision is to develop the means to improve cancer care delivery so patients in Ontario and beyond will live longer and without cancer. They will have better symptom control, survivorship and quality of life. This will translate not only into benefits to patients with cancer, but also their families and society, provincially, nationally and globally.

Current affiliations

  • Clinician-Scientist I, OICR;
  • Faculty, Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute;
  • Radiation Oncologist and Clinician Scientist, Cancer Centre of Southeastern Ontario;
  • Adjunct Scientist, Institute for Clinical Evaluative Sciences, Cancer Research Program;
  • Assistant Professor, Radiation Oncology, Department of Oncology, Queen’s University.

Research interests

  • Access to cancer care;
  • Quality of cancer care;
  • Value of cancer care.

Select publications

Hanna TP, Delaney GP, Barton MB.
The population benefit of radiotherapy for gynaecological cancer: Local control and survival estimates.
Radiother Oncol. 2016 Sep;120(3):370-377. doi: 10.1016/j.radonc.2016.04.008.
PMID:27127008


Jin CJ, Brundage MD, Cook EF, Miao Q, Hanna TP.
Quality of Radiation Therapy Referral and Utilisation Post-prostatectomy: A Population-based Study of Time Trends.
Clin Oncol (R Coll Radiol). 2016 Jul 25. pii: S0936-6555(16)30184-4. doi: 10.1016/j.clon.2016.07.006. [Epub ahead of print]
PMID:27461732


Hanna TP, Shafiq J, Delaney GP, Barton MB.
The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiation.
Radiother Oncol. 2015 Mar;114(3):389-94. doi: 10.1016/j.radonc.2015.02.005.
PMID:25733007


Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O’Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M.
Expanding global access to radiotherapy.
Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3. Review.
PMID: 26419354


Hanna TP, Shafiq J.
Estimating the population benefit of radiotherapy: using demand models to estimate achievable cancer outcomes.

Clin Oncol (R Coll Radiol). 2015 Feb;27(2):99-106. doi: 10.1016/j.clon.2014.10.011. Review.
PMID:25466333

Awards

  • University of New South Wales, Southwest Sydney Clinical School Paper of the Year 2016: Awarded for “Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012”;
  • Canadian Melanoma Conference Top Oral Abstract Research Excellence Award 2016.

Previous experience and education

  • PhD, Health Services Research, University of New South Wales, Sydney, Australia;
  • Radiation Oncology Fellow, Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Hospital, Sydney, New South Wales, Australia;
  • M.Sc., Epidemiology, Queen’s University;
  • Fellow, Health Services and Policy Research, Canadian Institutes of Health Research, Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute;
  • MD, Faculty of Medicine, University of Toronto;
  • Resident, Radiation Oncology, Kingston General Hospital, Cancer Centre of Southeastern Ontario.

Opportunities to collaborate

Objectives: For the next five years (2018-2022), my research has three overarching objectives:

  1. Quality: Improve the quality of care for brain cancer patients in Ontario and beyond.
  1. Value: Develop measures of value of care for melanoma and other cancers with administrative data.
  1. Access: Enhance access to quality radiotherapy in Ontario and beyond.

A newly developed population database for melanoma with stage information provides additional opportunities to investigate health services research questions using provincial administrative data sources.

Related links

Queen’s Cancer Research Institute – Cancer Care and Epidemiology 

Queen’s University Department of Oncology

Institute for Clinical Evaluative Science – Dr. Timothy Hanna

Contact

cce@queensu.ca.